Hrt Financial LP Akari Therapeutics PLC Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.38 - $1.74 $27,005 - $34,050	-19,569 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.59 - $1.87 $3,555 - $4,181	-2,236 Reduced 10.25%	19,569 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.69 - $2.85 $9,663 - $16,296	5,718 Added 35.54%	21,805 $37,000
Q1 2021 May 17, 2021	BUY	$1.81 - $3.88 $29,117 - $62,417	16,087 New	16,087 $42,000
Q4 2020 Feb 16, 2021	SELL	$1.5 - $2.02 $76,125 - $102,515	-50,750 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.58 - $2.37 $60,760 - $91,140	38,456 Added 312.8%	50,750 $88,000
Q2 2020 Aug 14, 2020	BUY	$1.16 - $2.61 $14,261 - $32,087	12,294 New	12,294 $26,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $59.3M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.